Page last updated: 2024-09-04

ym 872 and Brain Edema

ym 872 has been researched along with Brain Edema in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyata, K; Sasamata, M; Suzuki, M; Terai, K; Yamaguchi, T; Yatsugi, Si1
Asakura, T; Atsumi, T; Furukawa, T; Hoshino, S; Kobayashi, S; Takahashi, M; Teramoto, A1
Asakura, T; Atsumi, T; Furukawa, T; Hoshino, S; Kobayashi, S; Takahashi, M; Teramoto, A; Yamamoto, Y1

Other Studies

3 other study(ies) available for ym 872 and Brain Edema

ArticleYear
Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.
    European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3

    Topics: Animals; Atrophy; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Collagenases; Dose-Response Relationship, Drug; Hematoma; Heparin; Imidazoles; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

2003
The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats.
    Journal of neurotrauma, 2003, Volume: 20, Issue:3

    Topics: Animals; Body Temperature; Brain Edema; Brain Injuries; Cerebral Cortex; Glutamic Acid; Imidazoles; Male; Models, Animal; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Recovery of Function

2003
The glutamate AMPA receptor antagonist, YM872, attenuates regional cerebral edema and IgG immunoreactivity following experimental brain injury in rats.
    Acta neurochirurgica. Supplement, 2003, Volume: 86

    Topics: Animals; Body Water; Brain; Brain Edema; Brain Injuries; Imidazoles; Immunoglobulin G; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

2003